Rallybio Corporation (RLYB)
NASDAQ: RLYB · IEX Real-Time Price · USD
1.350
+0.010 (0.75%)
Jul 22, 2024, 11:23 AM EDT - Market open
Rallybio Employees
Rallybio had 43 employees as of December 31, 2023. The number of employees increased by 2 or 4.88% compared to the previous year.
Employees
43
Change (1Y)
2
Growth (1Y)
4.88%
Revenue / Employee
n/a
Profits / Employee
-$1,773,837
Market Cap
55.13M
Employees Chart
Employees History
| Date | Employees | Change | Growth |
|---|---|---|---|
| Dec 31, 2023 | 43 | 2 | 4.88% |
| Dec 31, 2022 | 41 | 6 | 17.14% |
| Dec 31, 2021 | 35 | - | - |
Related Stocks
| Company Name | Employees |
|---|---|
| Allurion Technologies | 504 |
| Neuronetics | 203 |
| Cytosorbents | 186 |
| LENSAR | 130 |
| Turnstone Biologics | 80 |
| CollPlant Biotechnologies | 75 |
| Passage Bio | 58 |
| Immix Biopharma | 17 |
RLYB News
- 13 days ago - Rallybio to Present at the 2024 Jones Healthcare Seaside Summit - Business Wire
- 5 weeks ago - Rallybio Announces Results of Epidemiological Analysis Demonstrating FNAIT Risk Across Racially and Ethnically Diverse Populations - Business Wire
- 2 months ago - Rallybio Reports First Quarter 2024 Financial Results and Provides Business Updates - Business Wire
- 2 months ago - Rallybio to Present at the 2024 Citizens JMP Life Sciences Conference - Business Wire
- 3 months ago - FNAIT Systematic Literature Review and Meta-Analysis Presented at the Academy of Managed Care Pharmacy 2024 Annual Meeting - Business Wire
- 3 months ago - Rallybio Announces Collaboration to Advance Therapeutic Solutions for Pregnant Individuals at Risk of Fetal and Neonatal Alloimmune Thrombocytopenia (FNAIT) - Business Wire
- 4 months ago - Rallybio Announces FNAIT Systematic Literature Review to be Presented at the AMCP 2024 Annual Meeting - Business Wire
- 4 months ago - Rallybio Reports Fourth Quarter and Full Year 2023 Financial Results - Business Wire